NDC 54348-989
Prochlorperazine 5 mg tablet
On the label: PharmPak, Inc.. It's repackaged: PharmPak, Inc. rebottles it from Jubilant Cadista Pharmaceuticals Inc.'s NDC 59746-113.
Where the pills inside were made
| Factory | Where | Role | Last FDA inspection |
|---|---|---|---|
| Havix Group Inc d/b/a Aavis Pharmaceuticals | Hoschton, GA, United States | Makes it | Problems found, fixed voluntarilyJul 25, 2025 · 2 inspections |
| Jubilant Generics Limited | Roorkee, India | Makes it | Problems found, fixed voluntarilyFeb 2, 2024 · 8 inspections, 3 with FDA action |
Recalls
- Dec 27, 2022 · Class III · Jubilant Cadista Pharmaceuticals, Inc.
Subpotent Drug: Out of specification for assay at the 18-month stability timepoint.
Lots: Lot#: 21P0336, Exp: 04/2023
Class I recalls are the most serious; Class III the least. A recall covers specific lots, listed on each recall.
Product details
- Generic drug
- Prochlorperazine: every company that makes it
- Form
- tablet, oral
- Strength
- 5 mg
- Approval
- ANDA ANDA040268
- On the market since
- Jul 11, 2019
- Package NDCs
54348-989-06- Official label
- DailyMed (National Library of Medicine), updated Oct 9, 2022
Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?